Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 16793711)

Published in Platelets on January 01, 1998

Authors

H M Sanderson1, S C Fox, R A Robbins, W Lösche, P Spangenberg, S Heptinstall

Author Affiliations

1: University of Nottingham, UK.

Articles by these authors

Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39

Teichoic acids and membrane function in bacteria. Nature (1970) 3.99

Chicken soup inhibits neutrophil chemotaxis in vitro. Chest (2000) 3.48

Acute and chronic effects of cigarette smoking on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 2.28

Modulation of airway epithelial cell ciliary beat frequency by nitric oxide. Biochem Biophys Res Commun (1993) 2.14

Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med (1997) 2.12

Differential inhibition by low-dose aspirin of human venous prostacyclin synthesis and platelet thromboxane synthesis. Lancet (1981) 1.92

Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol (1991) 1.91

Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet (1985) 1.84

Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med (2001) 1.82

Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone. Br J Pharmacol (1994) 1.82

Quality of life in ALS depends on factors other than strength and physical function. Neurology (2000) 1.70

Neutrophil chemotactic factors in bacterial pneumonia. Chest (1989) 1.69

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet (1988) 1.62

Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis (1989) 1.58

Ocuurrence of polymers containing N-acetylglucosamine-1-phosphate in bacterial walls. Nature (1968) 1.51

Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med (1995) 1.47

The alanine ester content and magnesium binding capacity of walls of Staphylococcus aureus H grown at different pH values. Biochim Biophys Acta (1973) 1.39

Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology (1992) 1.36

A comparison of the abilities of acetylsalicylic acid, flurbiprofen and indomethacin to inhibit the release reaction and prostaglandin synthesis in human blood platelets. Br J Pharmacol (1979) 1.34

Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res (1987) 1.33

The distribution of the glucosyl substituents along the chain of the teichoic acid in walls of Lactobacillus buchneri N.C.I.B. 8007. Biochem J (1969) 1.31

The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol (2000) 1.26

Platelet aggregation in whole blood determined using the Ultra-Flo 100 Platelet Counter. Thromb Haemost (1982) 1.25

Immunological functions of the pulmonary epithelium. Eur Respir J (1995) 1.22

Further studies on the glycerol teichoic acid of walls of Staphylococcus lactis I3. Location of the phosphodiester groups and their susceptibility to hydrolysis with alkali. Biochem J (1971) 1.20

Effects of a selective inhibitor of thromboxane synthetase on human blood platelet behaviour. Thromb Res (1980) 1.19

Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum. Pediatr Pulmonol (2000) 1.18

Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin. Br J Obstet Gynaecol (1994) 1.18

Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Pediatr Res (1986) 1.17

The balance between von-Willebrand factor and its cleaving protease ADAMTS13: biomarker in systemic inflammation and development of organ failure? Curr Mol Med (2010) 1.16

Inhibition of platelet behaviour by feverfew: a mechanism of action involving sulphydryl groups. Folia Haematol Int Mag Klin Morphol Blutforsch (1988) 1.14

Activation of the complement system in the adult respiratory distress syndrome. Am Rev Respir Dis (1987) 1.12

Bronchoscopy with bronchoalveolar lavage causes neutrophil recruitment to the lower respiratory tract. Am Rev Respir Dis (1991) 1.11

Adenosine diphosphate induced platelet aggregation and release reaction in heparinized platelet rich plasma and the influence of added citrate. Br J Haematol (1977) 1.08

TNF-alpha and IL-1 beta upregulate nitric oxide-dependent ciliary motility in bovine airway epithelium. Am J Physiol (1995) 1.06

Conditional ablation of Gata4 and Fog2 genes in mice reveals their distinct roles in mammalian sexual differentiation. Dev Biol (2011) 1.05

Respiratory tract inflammation in swine confinement workers studied using induced sputum and exhaled nitric oxide. J Toxicol Clin Toxicol (1998) 1.04

Head blebs: a new mutation on chromosome 4 of the mouse. J Hered (1981) 1.04

Endotoxin stimulates bronchial epithelial cells to release chemotactic factors for neutrophils. A potential mechanism for neutrophil recruitment, cytotoxicity, and inhibition of proliferation in bronchial inflammation. J Immunol (1991) 1.02

The effects of citrate and extracellular calcium ions on the platelet release reaction induced by adenosine diphosphate and collagen. Thromb Haemost (1979) 1.01

Airway epithelial cells: functional roles in airway disease. Am J Respir Crit Care Med (1994) 1.01

Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg (1995) 1.01

Ketone body metabolism in the neonate: development and the effect of diet. Fed Proc (1985) 1.01

Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood. Platelets (2001) 1.00

Procoagulant activity in patients with isolated severe head trauma. Crit Care Med (1998) 0.99

Mechanisms of neutrophil recruitment to the lung by grain dust exposure. Am Rev Respir Dis (1988) 0.99

Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit. J Pharm Pharmacol (1986) 0.98

Pseudo grey platelet syndrome--grey platelets due to degranulation in blood collected into EDTA. Eur J Haematol (1988) 0.98

Amounts of feverfew in commercial preparations of the herb. Lancet (1986) 0.97

The effect of alcohol ingestion on exhaled nitric oxide. Eur Respir J (1996) 0.97

Exhaled nitric oxide is increased in asthma. Chest (1995) 0.96

Glucocorticoid inhibition of RANTES expression in human lung epithelial cells. Am J Respir Cell Mol Biol (1995) 0.96

Blood platelet behaviour in mothers and neonates. Thromb Haemost (1985) 0.96

Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med (1993) 0.95

GPIIb-IIIa antagonists cause rapid disaggregation of platelets pre-treated with cytochalasin D. Evidence that the stability of platelet aggregates depends on normal cytoskeletal assembly. Platelets (1998) 0.95

Acetylcholine stimulates bronchial epithelial cells to release neutrophil and monocyte chemotactic activity. Am J Physiol (1992) 0.95

Organic dust toxic syndrome: an acute febrile reaction to organic dust exposure distinct from hypersensitivity pneumonitis. J Toxicol Clin Toxicol (1990) 0.95

Platelet-release reaction in myocardial infarction. Br Med J (1980) 0.95

Flow-cytometric detection of surface membrane alterations and concomitant changes in the cytoskeletal actin status of activated platelets. Cytometry (1990) 0.95

Tetracyclines and pulmonary inflammation. Endocr Metab Immune Disord Drug Targets (2007) 0.94

Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro. J Leukoc Biol (1993) 0.93

Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers. Eur Respir J (1990) 0.93

Gcglobulin functions as a cochemotaxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers. Am Rev Respir Dis (1991) 0.92

Smoke extract stimulates lung fibroblasts to release neutrophil and monocyte chemotactic activities. Am J Physiol (1999) 0.92

The platelet glycoprotein IIb/IIIa complex is involved in the adhesion of activated platelets to leukocytes. Thromb Haemost (1993) 0.92

Human platelet electrorotation change induced by activation: inducer specificity and correlation to serotonin release. Biochim Biophys Acta (1988) 0.92

Bronchial epithelial cells produce lung fibroblast chemotactic factor: fibronectin. Am J Respir Cell Mol Biol (1989) 0.92

A regimen for low-dose aspirin? Br Med J (Clin Res Ed) (1982) 0.92

Bronchial epithelial cells release chemoattractant activity for monocytes. Am J Physiol (1989) 0.92

Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth (1998) 0.91

IL-4 induces ICAM-1 expression in human bronchial epithelial cells and potentiates TNF-alpha. Am J Physiol (1999) 0.91

Endogenous nitric oxide in allergic airway disease. J Allergy Clin Immunol (2000) 0.91

Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin. Thromb Res (1986) 0.91

Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP. Eur J Pharmacol (1991) 0.91

Spontaneous platelet aggregation in whole blood: dependence on age and haematocrit. Lancet (1984) 0.91

Substance P increases neutrophil adhesion to bronchial epithelial cells. J Immunol (1994) 0.90

The use of a chelating ion-exchange resin to evaluate the effects of the extracellular calcium concentration on adenosine diphosphate induced aggregation of human blood platelets. Thromb Haemost (1976) 0.90

Beneficial effect of clopidogrel in a mouse model of polymicrobial sepsis. J Thromb Haemost (2009) 0.89

Acyclovir-responsive herpetic tracheobronchitis. Am J Med (1988) 0.89

Contribution of platelets to thrombus formation. Br Med Bull (1978) 0.89

Arachidonic acid metabolism by peripheral blood cells in psoriasis. Br J Dermatol (1986) 0.88

Corticosteroids as adjunctive therapy for diffuse alveolar hemorrhage associated with bone marrow transplantation. University of Nebraska Medical Center Bone Marrow Transplant Group. Am J Med (1994) 0.88

Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology (1996) 0.88

Aprotinin reduces interleukin-8 production and lung neutrophil accumulation after cardiopulmonary bypass. Anesth Analg (1996) 0.88

Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro. Antimicrob Agents Chemother (2001) 0.88

The teichoic acids of Micrococcus sp. 24. Biochem J (1971) 0.87

Effects of combining three different antiplatelet agents on platelets and leukocytes in whole blood in vitro. Br J Pharmacol (2001) 0.87

The bronchitis index. A semiquantitative visual scale for the assessment of airways inflammation. Chest (1993) 0.87

Bronchial epithelial cells regulate fibroblast proliferation. Am J Physiol (1995) 0.87

Increased generation of reactive oxygen species in mononuclear blood cells from hypercholesterolemic patients. Thromb Res (1993) 0.86

Advanced neuronavigation in skull base tumors and vascular lesions. Minim Invasive Neurosurg (2005) 0.86

A bioassay for inhibition of serotonin release from bovine platelets. J Nat Prod (1992) 0.85

Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups. J Pharm Pharmacol (1987) 0.85